First Time Loading...

Orthocell Ltd
ASX:OCC

Watchlist Manager
Orthocell Ltd Logo
Orthocell Ltd
ASX:OCC
Watchlist
Price: 0.39 AUD -1.27% Market Closed
Updated: May 7, 2024

Intrinsic Value

Orthocell Ltd. engages in the development and commercialization of cell therapies and related technologies. [ Read More ]

The intrinsic value of one OCC stock under the Base Case scenario is 0.52 AUD. Compared to the current market price of 0.39 AUD, Orthocell Ltd is Undervalued by 25%.

Key Points:
OCC Intrinsic Value
Base Case
0.52 AUD
Undervaluation 25%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Orthocell Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling OCC stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Orthocell Ltd

Provide an overview of the primary business activities
of Orthocell Ltd.

What unique competitive advantages
does Orthocell Ltd hold over its rivals?

What risks and challenges
does Orthocell Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Orthocell Ltd.

Provide P/S
for Orthocell Ltd.

Provide P/E
for Orthocell Ltd.

Provide P/OCF
for Orthocell Ltd.

Provide P/FCFE
for Orthocell Ltd.

Provide P/B
for Orthocell Ltd.

Provide EV/S
for Orthocell Ltd.

Provide EV/GP
for Orthocell Ltd.

Provide EV/EBITDA
for Orthocell Ltd.

Provide EV/EBIT
for Orthocell Ltd.

Provide EV/OCF
for Orthocell Ltd.

Provide EV/FCFF
for Orthocell Ltd.

Provide EV/IC
for Orthocell Ltd.

Show me price targets
for Orthocell Ltd made by professional analysts.

What are the Revenue projections
for Orthocell Ltd?

How accurate were the past Revenue estimates
for Orthocell Ltd?

What are the Net Income projections
for Orthocell Ltd?

How accurate were the past Net Income estimates
for Orthocell Ltd?

What are the EPS projections
for Orthocell Ltd?

How accurate were the past EPS estimates
for Orthocell Ltd?

What are the EBIT projections
for Orthocell Ltd?

How accurate were the past EBIT estimates
for Orthocell Ltd?

Compare the revenue forecasts
for Orthocell Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Orthocell Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Orthocell Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Orthocell Ltd compared to its peers.

Compare the P/E ratios
of Orthocell Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Orthocell Ltd with its peers.

Analyze the financial leverage
of Orthocell Ltd compared to its main competitors.

Show all profitability ratios
for Orthocell Ltd.

Provide ROE
for Orthocell Ltd.

Provide ROA
for Orthocell Ltd.

Provide ROIC
for Orthocell Ltd.

Provide ROCE
for Orthocell Ltd.

Provide Gross Margin
for Orthocell Ltd.

Provide Operating Margin
for Orthocell Ltd.

Provide Net Margin
for Orthocell Ltd.

Provide FCF Margin
for Orthocell Ltd.

Show all solvency ratios
for Orthocell Ltd.

Provide D/E Ratio
for Orthocell Ltd.

Provide D/A Ratio
for Orthocell Ltd.

Provide Interest Coverage Ratio
for Orthocell Ltd.

Provide Altman Z-Score Ratio
for Orthocell Ltd.

Provide Quick Ratio
for Orthocell Ltd.

Provide Current Ratio
for Orthocell Ltd.

Provide Cash Ratio
for Orthocell Ltd.

What is the historical Revenue growth
over the last 5 years for Orthocell Ltd?

What is the historical Net Income growth
over the last 5 years for Orthocell Ltd?

What is the current Free Cash Flow
of Orthocell Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Orthocell Ltd.

Financials

Balance Sheet Decomposition
Orthocell Ltd

Current Assets 21.7m
Cash & Short-Term Investments 19.6m
Receivables 861k
Other Current Assets 1.2m
Non-Current Assets 3.3m
PP&E 2.2m
Intangibles 1.1m
Current Liabilities 4.7m
Accounts Payable 1.3m
Accrued Liabilities 974.8k
Other Current Liabilities 2.4m
Non-Current Liabilities 18m
Long-Term Debt 616.7k
Other Non-Current Liabilities 17.4m
Efficiency

Earnings Waterfall
Orthocell Ltd

Revenue
6.1m AUD
Cost of Revenue
-1.4m AUD
Gross Profit
4.7m AUD
Operating Expenses
-15.3m AUD
Operating Income
-10.6m AUD
Other Expenses
3.2m AUD
Net Income
-7.4m AUD

Free Cash Flow Analysis
Orthocell Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

OCC Profitability Score
Profitability Due Diligence

Orthocell Ltd's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
33/100
Profitability
Score

Orthocell Ltd's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

OCC Solvency Score
Solvency Due Diligence

Orthocell Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
59/100
Solvency
Score

Orthocell Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OCC Price Targets Summary
Orthocell Ltd

Wall Street analysts forecast OCC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OCC is 0.56 AUD with a low forecast of 0.56 AUD and a high forecast of 0.58 AUD.

Lowest
Price Target
0.56 AUD
42% Upside
Average
Price Target
0.56 AUD
44% Upside
Highest
Price Target
0.58 AUD
48% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

OCC Price
Orthocell Ltd

1M 1M
-3%
6M 6M
+1%
1Y 1Y
+1%
3Y 3Y
-26%
5Y 5Y
+239%
10Y 10Y
+8%
Annual Price Range
0.39
52w Low
0.325
52w High
0.43
Price Metrics
Average Annual Return 79.26%
Standard Deviation of Annual Returns 170.6%
Max Drawdown -69%
Shares Statistics
Market Capitalization 77.7m AUD
Shares Outstanding 209 327 000
Percentage of Shares Shorted
N/A

OCC Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Orthocell Ltd Logo
Orthocell Ltd

Country

Australia

Industry

Biotechnology

Market Cap

77.7m AUD

Dividend Yield

0%

Description

Orthocell Ltd. engages in the development and commercialization of cell therapies and related technologies. The company is headquartered in Perth, Western Australia. The company went IPO on 2014-08-12. The firm is engaged in the development and commercialization of cell therapies and biological medical devices. The firm offers two main products, including CelGro and Ortho-ATI. CelGro is a naturally derived collagen medical device, which is designed for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons and cartilage. The company represents a paradigm shift in bone and soft tissue reconstruction. Ortho-ATI is a cell therapy for treatment of chronic tendon injuries. The treatment uses patient’s own tendon-derived cells to stimulate tendon regeneration and is delivered via a non-surgical ultrasound guided injection. The firm has a Good Manufacturing Process (GMP) facility. The facility is licensed by the Therapeutic Goods Administration (TGA) for the manufacture of human tendon cells and cartilage cells for the regeneration of damaged tendon and cartilage.

Contact

WESTERN AUSTRALIA
Perth
Building 191 Murdoch University, South Street Murdoch
+61893602888.0
http://www.orthocell.com.au/

IPO

2014-08-12

Employees

-

Officers

CEO, MD & Executive Director
Mr. Paul Frederick Anderson
Chief Financial Officer
Ms. Nicole Jane Telford
Chief Operating Officer
Mr. Alex McHenry
Chief Scientific Officer and Member of Medical & Scientific Advisory Board
Prof. Ming Hao Zheng
Chief Manufacturing Officer
Mr. Tony Macintyre
Company Secretary
Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D.

See Also

Discover More
What is the Intrinsic Value of one OCC stock?

The intrinsic value of one OCC stock under the Base Case scenario is 0.52 AUD.

Is OCC stock undervalued or overvalued?

Compared to the current market price of 0.39 AUD, Orthocell Ltd is Undervalued by 25%.